Medicine and Dentistry
Geriatric Assessment
100%
Cohort Analysis
33%
Malignant Neoplasm
33%
Computer Assisted Tomography
33%
Cost-Effectiveness Analysis
33%
Four Dimensional Computed Tomography
33%
Hospital Mortality
33%
Adverse Outcome
33%
Logistic Regression Analysis
33%
Cultural Diversity
33%
Adverse Drug Reaction
33%
Reconstructive Surgery
33%
Disease
33%
Frailty
25%
Multivariate Analysis
22%
Diagnosis
16%
Atrial Fibrillation
16%
Odds Ratio
16%
Nursing Home
16%
Percutaneous Aortic Valve Replacement
16%
Statin
16%
Coronary Artery Disease
16%
Diabetes Mellitus
16%
Medical Record
16%
Enteric Feeding
16%
Anticoagulant
16%
Health Care
16%
Population
16%
Diseases
15%
Glomerular Filtration Rate
11%
Emergency Care
11%
Patient Referral
11%
General Medicine
11%
Univariate Analysis
11%
Organ Systems
11%
Antiinfective Agent
11%
Health Outcomes
11%
Functional Status
8%
Prevalence
8%
Comorbidity
8%
Comminuted Fracture
6%
Clinical Assessment
5%
Orthopedic Surgeon
5%
Upper Limb Disorder
5%
Elbow Joint
5%
Nursing and Health Professions
Geriatric Assessment
59%
Feeding Tube
50%
Cost Effectiveness Analysis
33%
Area under the Curve
33%
Home Care
33%
Reconstructive Surgery
33%
Salvage Therapy
33%
Computer Assisted Tomography
33%
X-Ray Computed Tomography
33%
Four Dimensional Computed Tomography
33%
Longitudinal Analysis
33%
Arthritis
33%
Malignant Neoplasm
33%
Image Segmentation
33%
Health Care Personnel
20%
Teaching Hospital
16%
Receiver Operating Characteristic
16%
Nursing Home
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Transcatheter Aortic Valve Implantation
16%
Anticoagulant Agent
16%
Hospital Discharge
16%
Hospital Readmission
16%
Institutionalization
16%
Coronary Artery Disease
16%
Population
16%
Logistic Regression Analysis
16%
Diabetes Mellitus
16%
Health Care
16%
Cultural Diversity
16%
Adverse Outcome
16%
Atrial Fibrillation
16%
Frailty
12%
Comorbidity
7%
Prevalence
7%
Functional Status
7%
Pharmacology, Toxicology and Pharmaceutical Science
Polypharmacy
36%
Clinical Trial
33%
Clinical Pharmacology
33%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Proton Pump Inhibitor
33%
Malignant Neoplasm
33%
Antithrombocytic Agent
33%
Cholinergic Receptor Blocking Agent
33%
Nootropic Agent
33%
Non-Steroidal Anti-Inflammatory Drug
33%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
33%
Drug Resistance
16%
Prevalence
6%
Frailty
6%
Comorbidity
6%
Functional Status
6%